- Q2 2024 TCM Group A/S Earnings Call TranscriptAug 21, 2024kr64.4 (+1.26%)Earnings
- Q1 2024 TCM Group A/S Earnings Call TranscriptMay 16, 2024kr57 (+8.37%)Earnings
- Q4 2023 TCM Group A/S Earnings Call TranscriptFeb 28, 2024kr50.6 (+2.22%)Earnings
- TCM Group A/S Conference Call TranscriptOct 19, 2023
- Q2 2023 TCM Group A/S Earnings Call TranscriptAug 18, 2023kr62.2 (-3.42%)Earnings
- Q3 2022 TCM Group A/S Earnings Call TranscriptNov 15, 2022kr68.5 (-5.65%)Earnings
- Q2 2022 TCM Group A/S Earnings Call TranscriptAug 19, 2022kr85 (-5.56%)Earnings
- Q1 2022 TCM Group A/S Earnings Call TranscriptMay 18, 2022kr107 (+5.31%)Earnings
- Full Year 2021 TCM Group A/S Earnings Call TranscriptFeb 25, 2022kr124 (+0.40%)Earnings
- Q3 2021 TCM Group A/S Earnings Call TranscriptNov 12, 2021kr158 (-3.07%)Earnings
- Q2 2021 TCM Group A/S Earnings Call TranscriptAug 20, 2021kr158 (+2.60%)Earnings
- Q1 2021 TCM Group A/S Earnings Call TranscriptMay 19, 2021kr164 (-4.93%)Earnings
- Q4 2020 TCM Group A/S Earnings Call TranscriptFeb 24, 2021kr144.5 (-4.30%)Earnings
- Q3 2020 TCM Group A/S Earnings Call TranscriptNov 11, 2020kr128.5 (-4.46%)Earnings
- Q2 2020 Tcm Group A/S Earnings Call TranscriptAug 18, 2020kr129.5 (-5.47%)Earnings
- Q1 2020 Tcm Group A/S Earnings Call TranscriptMay 06, 2020kr94.6 (-1.87%)Earnings
- Q4 2019 Tcm Group A/S Earnings Call TranscriptFeb 26, 2020kr125 (-8.76%)Earnings
- Q3 2019 Tcm Group A/S Earnings Call TranscriptNov 06, 2019kr112 (+0.90%)Earnings
- Q2 2019 Tcm Group A/S Earnings Call TranscriptAug 14, 2019kr112 (+1.36%)Earnings
- Q1 2019 Tcm Group A/S Earnings Call TranscriptMay 07, 2019kr110 (-1.35%)Earnings
Q3 2019 Tcm Group A/S Earnings Call Transcript
/-
Yes. Good morning, ladies and gentlemen. We have been looking forward to making presentation on our Q3 report for TCM.
And I will, together with our CFO, Mogens Elbrond Pedersen, comment on the business and financial results, after which we'll be handing over to the operator for a Q&A session.
So please turn to Page #2. Q3 was another strong quarter for TCM with a revenue growth of 17.3%, and this growth was entirely an organic growth. We are pleased to see that we continue to gain market share. Business-to-consumer is growing above market growth rates, and at the same time, business-to-business continued to have the highest growth rates. And we can see that our strategy of expanding across the business-to-business categories is successful.
Revenue for the quarter was DKK 238 million compared to DKK 202 million in Q3 last year. Adjusted EBITA increased by 19.9% to DKK 39 million, corresponding to an EBITA margin of 16.4%. This is slightly higher than the Q3 last year, which was at 16.1%. Our net working
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)